Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for early retinopathy of prematurity
ISRCTN18523491Phase 2Completed
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of propranolol in retinopathy of prematurity (ROP) (2 arms), sponsored by Meyer Children's Hospital IRCCS. Primary endpoints: Safety of propranolol administration and Laboratory safety monitoring. Started Jan 2010; status: completed.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on ISRCTN18523491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18523491.